These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28975684)

  • 1. Salvinorin A reduces neuropathic nociception in the insular cortex of the rat.
    Coffeen U; Canseco-Alba A; Simón-Arceo K; Almanza A; Mercado F; León-Olea M; Pellicer F
    Eur J Pain; 2018 Feb; 22(2):311-318. PubMed ID: 28975684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathic and inflammatory antinociceptive effects and electrocortical changes produced by Salvia divinorum in rats.
    Simón-Arceo K; González-Trujano ME; Coffeen U; Fernández-Mas R; Mercado F; Almanza A; Contreras B; Jaimes O; Pellicer F
    J Ethnopharmacol; 2017 Jul; 206():115-124. PubMed ID: 28502907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors.
    Fichna J; Dicay M; Lewellyn K; Janecka A; Zjawiony JK; MacNaughton WK; Storr MA
    Inflamm Bowel Dis; 2012 Jun; 18(6):1137-45. PubMed ID: 21953882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo.
    Aviello G; Borrelli F; Guida F; Romano B; Lewellyn K; De Chiaro M; Luongo L; Zjawiony JK; Maione S; Izzo AA; Capasso R
    J Mol Med (Berl); 2011 Sep; 89(9):891-902. PubMed ID: 21499737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
    Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
    Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents.
    Walentiny DM; Vann RE; Warner JA; King LS; Seltzman HH; Navarro HA; Twine CE; Thomas BF; Gilliam AF; Gilmour BP; Carroll FI; Wiley JL
    Psychopharmacology (Berl); 2010 Jun; 210(2):275-84. PubMed ID: 20354680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.
    Capasso R; Borrelli F; Cascio MG; Aviello G; Huben K; Zjawiony JK; Marini P; Romano B; Di Marzo V; Capasso F; Izzo AA
    Br J Pharmacol; 2008 Nov; 155(5):681-9. PubMed ID: 18622408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.
    Kivell BM; Paton KF; Kumar N; Morani AS; Culverhouse A; Shepherd A; Welsh SA; Biggerstaff A; Crowley RS; Prisinzano TE
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30314288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
    Cruz A; Domingos S; Gallardo E; Martinho A
    Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement.
    Braida D; Limonta V; Pegorini S; Zani A; Guerini-Rocco C; Gori E; Sala M
    Psychopharmacology (Berl); 2007 Mar; 190(4):441-8. PubMed ID: 17219220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly selective non-opioid kappa opioid receptor (KOR) agonist salvinorin A protects against forebrain ischemia-induced brain injury in rats.
    Xin J; Zhang Y; He Z; Wang Z
    Brain Res; 2016 Apr; 1637():168-176. PubMed ID: 26907190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward.
    Braida D; Limonta V; Capurro V; Fadda P; Rubino T; Mascia P; Zani A; Gori E; Fratta W; Parolaro D; Sala M
    Biol Psychiatry; 2008 Feb; 63(3):286-92. PubMed ID: 17920565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors.
    Fichna J; Schicho R; Andrews CN; Bashashati M; Klompus M; McKay DM; Sharkey KA; Zjawiony JK; Janecka A; Storr MA
    Neurogastroenterol Motil; 2009 Dec; 21(12):1326-e128. PubMed ID: 19650775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical syntheses of the salvinorin chemotype of KOR agonist.
    Hill SJ; Brion AUCM; Shenvi RA
    Nat Prod Rep; 2020 Nov; 37(11):1478-1496. PubMed ID: 32808003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analgesic and anti-inflammatory effects of Salvinorin A analogue β-tetrahydropyran Salvinorin B in mice.
    Paton KF; Kumar N; Crowley RS; Harper JL; Prisinzano TE; Kivell BM
    Eur J Pain; 2017 Jul; 21(6):1039-1050. PubMed ID: 28158929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive effects of Salvia divinorum and bioactive salvinorins in experimental pain models in mice.
    Tlacomulco-Flores LL; Déciga-Campos M; González-Trujano ME; Carballo-Villalobos AI; Pellicer F
    J Ethnopharmacol; 2020 Feb; 248():112276. PubMed ID: 31593812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrical stimulation of the insular cortex as a novel target for the relief of refractory pain: An experimental approach in rodents.
    Dimov LF; Toniolo EF; Alonso-Matielo H; de Andrade DC; Garcia-Larrea L; Ballester G; Teixeira MJ; Dale CS
    Behav Brain Res; 2018 Jul; 346():86-95. PubMed ID: 29191577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors.
    Sałaga M; Polepally PR; Zakrzewski PK; Cygankiewicz A; Sobczak M; Kordek R; Zjawiony JK; Krajewska WM; Fichna J
    Biochem Pharmacol; 2014 Dec; 92(4):618-26. PubMed ID: 25265540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
    Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats.
    Braida D; Donzelli A; Martucci R; Capurro V; Sala M
    Int J Toxicol; 2011 Dec; 30(6):650-61. PubMed ID: 21960665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.